APRE - Aprea Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APRE is currently covered by 1 analysts with an average price target of $18.93. This is a potential upside of $14.82 (360.58%) from yesterday's end of day stock price of $4.11.

Aprea Therapeutics's activity chart (see below) currently has 12 price targets and 14 ratings on display. The stock rating distribution of APRE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 23.5 days.

Highest price target for APRE is $20, Lowest price target is $20, average price target is $18.93.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 24-Jun-2024. First documented stock forecast 28-Oct-2019.

Best performing analysts who are covering APRE - Aprea Therapeutics:

Jeffrey Hung Andrew Fein Gregory Renza Madhu Kumar Jessica Fye Joseph Pantginis

Currently out of the existing stock ratings of APRE, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

20

$15.89 (386.62%)

20

21 days ago

0/6 (0%)

$15.86 (383.09%)

Hold

80

$75.89 (1846.47%)

160

2 years 3 months 29 days ago

1/4 (25%)

$40.2 (101.01%)

44

Hold

40

$35.89 (873.24%)

80

2 years 3 months 29 days ago

3/4 (75%)

$0.2 (0.50%)

21

Sell

500

2 years 10 months 25 days ago

1/1 (100%)

$47.6 (10.52%)

2

Sell

60

$55.85 (1345.78%)

100

2 years 11 months 3 days ago

3/3 (100%)

$-20.8 (-25.74%)

72

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APRE (Aprea Therapeutics) average time for price targets to be met?

On average it took 23.5 days on average for the stock forecasts to be realized with a an average price target met ratio 58.33

Which analyst has the current highest performing score on APRE (Aprea Therapeutics) with a proven track record?

JEFFREY HUNG

Which analyst has the current lower performing score on APRE (Aprea Therapeutics) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on APRE (Aprea Therapeutics)?

Jeffrey Hung works at MORGAN STANLEY and has 6 price targets and 3 ratings on APRE

Which analyst is the currently most bullish on APRE (Aprea Therapeutics)?

Gregory Renza with highest potential upside - $75.89

Which analyst is the currently most reserved on APRE (Aprea Therapeutics)?

Jessica Fye with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?